Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-25 @ 1:40 AM
NCT ID:
NCT00521794
Eligibility Criteria:
Inclusion Criteria:
* Clinically confirmed diagnosis of ATS as defined by at least two of the following three criteria:
1. Presence of clear-cut episodes of transient muscle weakness with or without a fixed deficit, typically following exertion or prolonged rest OR atypical history with otherwise typical exam findings (absent reflexes with normal sensation during an episode) OR unexplained hypokalemia between episodes OR abnormal long-exercise nerve conduction study
2. Heart conduction defects: prolonged QTc interval on 12-lead electrocardiogram OR ventricular ectopy, including uniform or multifocal PVCs, polymorphic VT, or bidirectional VT
3. Presence of two or more of the following physical features: low set ears, hypertelorism, small mandible, clinodactyly, syndactyly, micromelia of hands or feet --OR--
* Meets one of the above three criteria and has at least one family member with two of the criteria --OR--
* Does not meet the above three criteria, but possesses a mutation in the KCNJ2 gene
Exclusion Criteria:
* Less than 10 years of age
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
10 Years
Study:
NCT00521794
Study Brief:
Protocol Section:
NCT00521794